Wednesday, October 28, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 09:44 ETSource: STAT

From the source

STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B program

Read at statnews.com
PeptiPrescribed peptides from $99/moSee all →